BGA Stock Overview
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
BioNeutra Global Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.14 |
| 52 Week High | CA$0.16 |
| 52 Week Low | CA$0.005 |
| Beta | 1.95 |
| 1 Month Change | 21.74% |
| 3 Month Change | 600.00% |
| 1 Year Change | 460.00% |
| 3 Year Change | -49.09% |
| 5 Year Change | -75.00% |
| Change since IPO | -68.89% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)
Dec 30
A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)
Aug 24We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed
Sep 15Is BioNeutra Global (CVE:BGA) Using Too Much Debt?
Jul 12Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?
Mar 29Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?
Dec 14Shareholder Returns
| BGA | CA Food | CA Market | |
|---|---|---|---|
| 7D | 27.3% | -2.4% | -1.5% |
| 1Y | 460.0% | -21.0% | 4.7% |
Return vs Industry: BGA exceeded the Canadian Food industry which returned -21% over the past year.
Return vs Market: BGA exceeded the Canadian Market which returned 4.7% over the past year.
Price Volatility
| BGA volatility | |
|---|---|
| BGA Average Weekly Movement | 144.5% |
| Food Industry Average Movement | 3.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BGA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BGA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jianhua Zhu | www.bioneutra.ca |
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides. The company’s lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
BioNeutra Global Corporation Fundamentals Summary
| BGA fundamental statistics | |
|---|---|
| Market cap | CA$6.54m |
| Earnings (TTM) | -CA$4.71m |
| Revenue (TTM) | CA$11.27m |
0.6x
P/S Ratio-1.4x
P/E RatioIs BGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGA income statement (TTM) | |
|---|---|
| Revenue | CA$11.27m |
| Cost of Revenue | CA$10.08m |
| Gross Profit | CA$1.19m |
| Other Expenses | CA$5.90m |
| Earnings | -CA$4.71m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | 10.54% |
| Net Profit Margin | -41.80% |
| Debt/Equity Ratio | -93.1% |
How did BGA perform over the long term?
See historical performance and comparison